Yeast could deliver insulin as a spray
UK scientists think that diabetes patients could be able to receive insulin via a nasal spray using yeast, which would open up the way for a spray to be developed to replace injections.
Archives for February 13, 2006
Matthey buys Davy from Yukos for $71m
Johnson Matthey, a British catalyst, precious metals and chemicals firm with a division that provides contract manufacturing services of active pharmaceutical ingredients (APIs) to pharmaceutical companies, has bought chemical technology licence...
Wound care market benefits from antiseptic wand
Dermisonics have come up with the first working model of an antiseptic delivery system, which the company hope to provide the US army with a battlefield version, reducing the severity of infection providing a much needed tool for medics in the field.
In-PharmaTechnologist insulin series
As Exubera dives into murky waters, will it sink or swim?
Recently approved, Exubera is the first in a line up of needle-free insulins promising to win the hearts of diabetics. Amidst all the hype, some market analysts predict it will be a blockbuster, while others believe it has been overvalued. Many...
Amgen expands on Puerto Rico with $1bn investment
Responding to growing demand, Biotechnology giant Amgen has announced an expansion of its manufacturing facilities in Puerto Rico, investing $1 billion (€835 million) in the project over the next four years.